Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Enhancing surgical safety using digital multimedia technology.

Dixon JL, Mukhopadhyay D, Hunt J, Jupiter D, Smythe WR, Papaconstantinou HT.

Am J Surg. 2016 Jun;211(6):1095-8. doi: 10.1016/j.amjsurg.2015.08.023. Epub 2015 Oct 22.

PMID:
26547406
2.

Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population.

Dixon JL, Copeland LA, Zeber JE, MacCarthy AA, Reznik SI, Smythe WR, Rascoe PA.

Dis Esophagus. 2016 Oct;29(7):747-751. doi: 10.1111/dote.12402. Epub 2015 Oct 12.

PMID:
26455587
3.

RECOMBINANT BCL-XL ATTENUATES VASCULAR HYPERPERMEABILITY IN A RAT MODEL OF HEMORRHAGIC SHOCK.

Tharakan B, McNeal SI Jr, Hunter FA, Sawant DA, Smythe WR, Childs EW.

Cell Death Discov. 2015;1. pii: 15042. Epub 2015 Nov 9.

4.

Can laparoscopic cholecystectomy be performed with a positive margin at medicaid reimbursement rates?

Frazee RC, Elliott VG, Larsen W, Lerner S, Minnis KW, Huber C, Nolan J, Papaconstantinou H, Smythe WR.

J Am Coll Surg. 2014 Apr;218(4):546-51. doi: 10.1016/j.jamcollsurg.2013.12.031. Epub 2014 Jan 8.

PMID:
24529812
5.

Doxycycline attenuates burn-induced microvascular hyperpermeability.

Stagg HW, Whaley JG, Tharakan B, Hunter FA, Jupiter D, Little DC, Davis ML, Smythe WR, Childs EW.

J Trauma Acute Care Surg. 2013 Dec;75(6):1040-6; discussion 1046. doi: 10.1097/TA.0b013e3182aa9c79.

PMID:
24256679
6.

Surgical safety checklist and operating room efficiency: results from a large multispecialty tertiary care hospital.

Papaconstantinou HT, Smythe WR, Reznik SI, Sibbitt S, Wehbe-Janek H.

Am J Surg. 2013 Dec;206(6):853-9; discussion 859-60. doi: 10.1016/j.amjsurg.2013.08.016. Epub 2013 Oct 8.

PMID:
24112671
7.

Thymic neuroendocrine carcinoma producing ectopic adrenocorticotropic hormone and Cushing's syndrome.

Dixon JL, Borgaonkar SP, Patel AK, Reznik SI, Smythe WR, Rascoe PA.

Ann Thorac Surg. 2013 Oct;96(4):e81-e83. doi: 10.1016/j.athoracsur.2013.04.140.

PMID:
24088497
8.

Implementation of a surgical safety checklist: impact on surgical team perspectives.

Papaconstantinou HT, Jo C, Reznik SI, Smythe WR, Wehbe-Janek H.

Ochsner J. 2013 Fall;13(3):299-309.

9.

Surgical Safety Checklist compliance: a job done poorly!

Sparks EA, Wehbe-Janek H, Johnson RL, Smythe WR, Papaconstantinou HT.

J Am Coll Surg. 2013 Nov;217(5):867-73.e1-3. doi: 10.1016/j.jamcollsurg.2013.07.393. Epub 2013 Aug 21.

PMID:
23973104
10.

Quick Response codes for surgical safety: a prospective pilot study.

Dixon JL, Smythe WR, Momsen LS, Jupiter D, Papaconstantinou HT.

J Surg Res. 2013 Sep;184(1):157-63. doi: 10.1016/j.jss.2013.06.036. Epub 2013 Jul 11.

PMID:
23907012
11.

Surgical resection of giant fibrous dysplasia for near respiratory collapse.

Dixon JL, Smythe WR, Rascoe PA, Reznik SI.

Ann Thorac Surg. 2013 Jun;95(6):e135-7. doi: 10.1016/j.athoracsur.2012.11.012.

PMID:
23706463
12.

Surgical care improvement project and surgical site infections: can integration in the surgical safety checklist improve quality performance and clinical outcomes?

Tillman M, Wehbe-Janek H, Hodges B, Smythe WR, Papaconstantinou HT.

J Surg Res. 2013 Sep;184(1):150-6. doi: 10.1016/j.jss.2013.03.048. Epub 2013 Apr 6.

PMID:
23582762
13.

Are commercial negative pressure systems worth the cost in open abdomen management?

Frazee RC, Abernathy SW, Jupiter DC, Hendricks JC, Davis M, Regner JL, Isbell T, Smith RW, Smythe WR.

J Am Coll Surg. 2013 Apr;216(4):730-3; discussion 733-5. doi: 10.1016/j.jamcollsurg.2012.12.035. Epub 2013 Feb 13.

PMID:
23415556
14.

Microvascular endothelial cell hyperpermeability induced by endogenous caspase 3 activator staurosporine.

Sawant DA, Tharakan B, Tobin RP, Reilly J, Hunter FA, Newell MK, Smythe WR, Childs EW.

J Trauma Acute Care Surg. 2013 Feb;74(2):516-23. doi: 10.1097/TA.0b013e31827a0620.

PMID:
23354245
15.

Inhibition of Fas-Fas ligand interaction attenuates microvascular hyperpermeability following hemorrhagic shock.

Sawant DA, Tharakan B, Tobin RP, Stagg HW, Hunter FA, Newell MK, Smythe WR, Childs EW.

Shock. 2013 Feb;39(2):161-7. doi: 10.1097/SHK.0b013e31827bba73.

16.

The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition.

Peddaboina C, Jupiter D, Fletcher S, Yap JL, Rai A, Tobin RP, Jiang W, Rascoe P, Rogers MK, Smythe WR, Cao X.

BMC Cancer. 2012 Nov 21;12:541. doi: 10.1186/1471-2407-12-541.

17.

Molecular pathogenesis of malignant mesothelioma.

Rascoe PA, Jupiter D, Cao X, Littlejohn JE, Smythe WR.

Expert Rev Mol Med. 2012 May 24;14:e12. doi: 10.1017/erm.2012.6. Review.

PMID:
22622048
18.

Relaxation of the rigid backbone of an oligoamide-foldamer-based α-helix mimetic: identification of potent Bcl-xL inhibitors.

Yap JL, Cao X, Vanommeslaeghe K, Jung KY, Peddaboina C, Wilder PT, Nan A, MacKerell AD Jr, Smythe WR, Fletcher S.

Org Biomol Chem. 2012 Apr 21;10(15):2928-33. doi: 10.1039/c2ob07125h. Epub 2012 Mar 7.

PMID:
22395339
19.

β-Catenin dynamics in the regulation of microvascular endothelial cell hyperpermeability.

Tharakan B, Hellman J, Sawant DA, Tinsley JH, Parrish AR, Hunter FA, Smythe WR, Childs EW.

Shock. 2012 Mar;37(3):306-11. doi: 10.1097/SHK.0b013e318240b564.

PMID:
22089197
20.

Benign emptying of the postpneumonectomy space.

Merritt RE, Reznik SI, DaSilva MC, Sugarbaker DJ, Whyte RI, Donahue DM, Hoang CD, Smythe WR, Shrager JB.

Ann Thorac Surg. 2011 Sep;92(3):1076-81; discussion 1081-2. doi: 10.1016/j.athoracsur.2011.04.082.

PMID:
21871304
21.

Chondrosarcoma of the thorax.

Rascoe PA, Reznik SI, Smythe WR.

Sarcoma. 2011;2011:342879. doi: 10.1155/2011/342879. Epub 2011 May 11.

22.

Role of β-catenin in regulating microvascular endothelial cell hyperpermeability.

Sawant DA, Tharakan B, Hunter FA, Smythe WR, Childs EW.

J Trauma. 2011 Feb;70(2):481-7; discussion 487-8. doi: 10.1097/TA.0b013e31820b3ed7.

PMID:
21307750
23.

Inhibition of VE-cadherin proteasomal degradation attenuates microvascular hyperpermeability.

Sawant DA, Tharakan B, Adekanbi A, Hunter FA, Smythe WR, Childs EW.

Microcirculation. 2011 Jan;18(1):46-55. doi: 10.1111/j.1549-8719.2010.00067.x.

PMID:
21166925
24.

Curcumin inhibits reactive oxygen species formation and vascular hyperpermeability following haemorrhagic shock.

Tharakan B, Hunter FA, Smythe WR, Childs EW.

Clin Exp Pharmacol Physiol. 2010 Sep;37(9):939-44. doi: 10.1111/j.1440-1681.2010.05414.x. Epub 2010 May 28.

PMID:
20528978
25.

The future of academic surgery.

Smythe WR.

Acad Med. 2010 May;85(5):768-74. doi: 10.1097/ACM.0b013e3181d748c3.

PMID:
20520023
26.

Characterization of bortezomib-adapted I-45 mesothelioma cells.

Zhang L, Littlejohn JE, Cui Y, Cao X, Peddaboina C, Smythe WR.

Mol Cancer. 2010 May 18;9:110. doi: 10.1186/1476-4598-9-110.

27.

On being a doctor. Mattie's visit.

Smythe WR.

Ann Intern Med. 2010 Apr 6;152(7):470-1. doi: 10.7326/0003-4819-152-7-201004060-00014. No abstract available.

PMID:
20368655
28.

Cyclosporine A--protection against microvascular hyperpermeability is calcineurin independent.

Childs EW, Tharakan B, Nurudeen S, Delmas TL, Hellman J, Christie T, Hunter FA, Smythe WR.

Am J Surg. 2010 Apr;199(4):542-8. doi: 10.1016/j.amjsurg.2009.11.002.

29.

17beta-estradiol mediated protection against vascular leak after hemorrhagic shock: role of estrogen receptors and apoptotic signaling.

Childs EW, Tharakan B, Hunter FA, Smythe WR.

Shock. 2010 Sep;34(3):229-35. doi: 10.1097/SHK.0b013e3181d75b50.

30.

Up-regulation of Bcl-xl by hepatocyte growth factor in human mesothelioma cells involves ETS transcription factors.

Cao X, Littlejohn J, Rodarte C, Zhang L, Martino B, Rascoe P, Hamid K, Jupiter D, Smythe WR.

Am J Pathol. 2009 Nov;175(5):2207-16. doi: 10.2353/ajpath.2009.090070. Epub 2009 Oct 15.

31.

(-)-Deprenyl inhibits vascular hyperpermeability after hemorrhagic shock.

Tharakan B, Whaley JG, Hunter FA, Smythe WR, Childs EW.

Shock. 2010 Jan;33(1):56-63. doi: 10.1097/SHK.0b013e3181a7fb7c.

32.

Cyclosporine A prevents vascular hyperpermeability after hemorrhagic shock by inhibiting apoptotic signaling.

Tharakan B, Holder-Haynes JG, Hunter FA, Smythe WR, Childs EW.

J Trauma. 2009 Apr;66(4):1033-9. doi: 10.1097/TA.0b013e31816c905f.

PMID:
19359911
33.

Management of primary pulmonary artery sarcomas.

Blackmon SH, Rice DC, Correa AM, Mehran R, Putnam JB, Smythe WR, Walkes JC, Walsh GL, Moran C, Singh H, Vaporciyan AA, Reardon M.

Ann Thorac Surg. 2009 Mar;87(3):977-84. doi: 10.1016/j.athoracsur.2008.08.018. Review.

PMID:
19231448
34.

17beta-estradiol mediates protection against microvascular endothelial cell hyperpermeability.

Tharakan B, Corprew R, Hunter FA, Whaley JG, Smythe WR, Childs EW.

Am J Surg. 2009 Feb;197(2):147-54. doi: 10.1016/j.amjsurg.2008.10.003.

PMID:
19185107
35.

A possible association between aprotinin and improved survival after radical surgery for mesothelioma.

Norman PH, Thall PF, Purugganan RV, Riedel BJ, Thakar DR, Rice DC, Huynh L, Qiao W, Wen S, Smythe WR.

Cancer. 2009 Feb 15;115(4):833-41. doi: 10.1002/cncr.24108.

36.

Bring out your dead?

Smythe WR.

Pharos Alpha Omega Alpha Honor Med Soc. 2008 Autumn;71(4):10-4; discussion 15. No abstract available.

PMID:
19014114
37.

Alpha-lipoic acid attenuates hemorrhagic shock-induced apoptotic signaling and vascular hyperpermeability.

Tharakan B, Hunter FA, Smythe WR, Childs EW.

Shock. 2008 Nov;30(5):571-7. doi: 10.1097/SHK.0b013e31816a7308.

PMID:
18923301
38.

Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts.

Littlejohn JE, Cao X, Miller SD, Ozvaran MK, Jupiter D, Zhang L, Rodarte C, Smythe WR.

Int J Cancer. 2008 Jul 1;123(1):202-8. doi: 10.1002/ijc.23452.

39.

Angiopoietin-1 inhibits intrinsic apoptotic signaling and vascular hyperpermeability following hemorrhagic shock.

Childs EW, Tharakan B, Byrge N, Tinsley JH, Hunter FA, Smythe WR.

Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2285-95. doi: 10.1152/ajpheart.01361.2007. Epub 2008 Mar 14.

40.

Optimal exposure of thoracic inlet vascular structures: transmanubrial approach.

Smythe WR, Reznik SI.

Semin Vasc Surg. 2008 Mar;21(1):21-4. doi: 10.1053/j.semvascsurg.2007.11.005. Review.

PMID:
18342731
41.

Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.

Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, Walsh GL, Swisher SG, Hofstetter WL, Mehran RJ, Roth JA, Liao Z, Smythe WR.

Ann Thorac Surg. 2007 Nov;84(5):1685-92; discussion 1692-3.

PMID:
17954086
42.

Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications.

Bakaeen F, Rice D, Correa AM, Walsh GL, Vaporciyan AA, Putnam JB, Swisher SG, Roth JA, Huh J, Chu D, Smythe WR.

Ann Thorac Surg. 2007 Sep;84(3):982-6.

PMID:
17720413
43.

Malignant mesothelioma: natural history, pathologic features and future therapies.

Camacho LH, Mora-Bowen A, Munden R, Smythe WR, Ordoñez NG.

Am J Med. 2007 Jul;120(7):e7-9. No abstract available.

PMID:
17602922
44.

Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.

Rice DC, Smythe WR, Liao Z, Guerrero T, Chang JY, McAleer MF, Jeter MD, Correa A, Vaporciyan AA, Liu HH, Komaki R, Forster KM, Stevens CW.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):350-7. Epub 2007 Apr 30.

PMID:
17467922
45.

Bcl2/bcl-xL inhibitor engenders apoptosis and increases chemosensitivity in mesothelioma.

Cao X, Rodarte C, Zhang L, Morgan CD, Littlejohn J, Smythe WR.

Cancer Biol Ther. 2007 Feb;6(2):246-52. Epub 2007 Feb 26.

PMID:
17224645
46.

Cardiac autotransplantation for primary cardiac tumors.

Reardon MJ, Malaisrie SC, Walkes JC, Vaporciyan AA, Rice DC, Smythe WR, DeFelice CA, Wojciechowski ZJ.

Ann Thorac Surg. 2006 Aug;82(2):645-50.

PMID:
16863779
47.

Radiotherapy for mesothelioma.

Stevens CW, Forster KM, Smythe WR, Rice D.

Hematol Oncol Clin North Am. 2005 Dec;19(6):1099-115, vii. Review.

PMID:
16325126
48.

The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.

Martin LW, Correa AM, Hofstetter W, Hong WK, Komaki R, Putnam JB Jr, Rice DC, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Roth JA.

J Thorac Cardiovasc Surg. 2005 Dec;130(6):1601-10.

49.

Extended surgical staging for potentially resectable malignant pleural mesothelioma.

Rice DC, Erasmus JJ, Stevens CW, Vaporciyan AA, Wu JS, Tsao AS, Walsh GL, Swisher SG, Hofstetter WL, Ordonez NG, Smythe WR.

Ann Thorac Surg. 2005 Dec;80(6):1988-92; discussion 1992-3.

PMID:
16305830
50.

Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction.

Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam JB, Smythe WR, Feig BW, Mansfield PF, Pisters PW, Torres MT, Walsh GL.

J Thorac Cardiovasc Surg. 2005 Nov;130(5):1391-8. Epub 2005 Oct 13.

Supplemental Content

Loading ...
Support Center